<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/804"/><api:result><api:object category="publication" id="804" last-affected-when="2024-04-14T08:25:45.09+01:00" last-modified-when="2024-04-14T08:25:45.09+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/804" created-when="2010-05-17T13:46:29.807+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2001-12-24</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1364558" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1046/j.1365-2141.2000.01845.x" last-modified-when="2023-11-04T17:16:26.423+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:p&gt;Interleukin‐6 (IL‐6) is an important growth and survival factor for myeloma cells. However, the identity of the cells producing IL‐6 &lt;jats:italic&gt;in vivo&lt;/jats:italic&gt; remains unclear. Myeloma cells are found closely associated with sites of active bone turnover, and cells of the osteogenic lineage, including bone marrow osteoprogenitors, osteoblasts and bone lining cells, may therefore be ideally placed to synthesize IL‐6. We have examined the possibility that human osteogenic cells may produce IL‐6 in response to stimulation by myeloma cells. Primary human osteoblasts (hOBs) were isolated from normal donors, co‐cultured with the human myeloma cell lines, JJN‐3, RPMI‐8226 and NCI‐H929, and the amount of IL‐6 released was determined by enzyme‐linked immunosorbent assay (ELISA). All myeloma cells stimulated a significant increase in the production of IL‐6 when cultured with hOBs (&lt;jats:italic&gt;P&lt;/jats:italic&gt; &amp;lt; 0.05). Prior fixation of hOBs completely abrogated release of IL‐6 in the co‐cultures. In contrast, fixed myeloma cells retained the ability to induce IL‐6 production, suggesting that hOBs were the principal source of IL‐6. Physical separation of myeloma cells from hOBs using transwell inserts caused a partial inhibition of IL‐6 release (&lt;jats:italic&gt;P&lt;/jats:italic&gt; &amp;lt; 0.05), whereas the addition of media conditioned by myeloma cells to cultures of hOBs stimulated a significant increase in IL‐6 production (&lt;jats:italic&gt;P&lt;/jats:italic&gt; &amp;lt; 0.05). hOBs secreted greater amounts of IL‐6 than human bone marrow stromal cells (hBMSCs) (2.2‐ to 3.5‐fold, &lt;jats:italic&gt;P&lt;/jats:italic&gt; &amp;lt; 0.05), but incubating hBMSCs with dexamethasone to stimulate osteoblastic differentiation resulted in an increase in their ability to produce IL‐6 (1.7‐ to 4.8‐fold, &lt;jats:italic&gt;P&lt;/jats:italic&gt; &amp;lt; 0.05) and to respond to myeloma cells (&lt;jats:italic&gt;P&lt;/jats:italic&gt; &amp;lt; 0.05). These data clearly indicate that cells of the osteoblast lineage release significant amounts of IL‐6 in response to stimulation by myeloma cells and may contribute to the IL‐6 that promotes the proliferation and survival of myeloma cells &lt;jats:italic&gt;in vivo&lt;/jats:italic&gt;.&lt;/jats:p&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Karadag</api:last-name><api:initials></api:initials></api:person><api:person><api:last-name>Oyajobi</api:last-name><api:initials></api:initials></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials></api:initials></api:person><api:person><api:links><api:link type="elements/user" id="18810" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18810"/></api:links><api:last-name>Russell</api:last-name><api:initials></api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials></api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.2000.01845.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.2000.01845.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.2000.01845.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2141</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Haematology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>24</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>383</api:begin-page><api:end-page>390</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1046/j.1365-2141.2000.01845.x</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>29</api:day><api:month>10</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>108</api:text></api:field></api:native></api:record><api:record format="native" id="95829" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0034012201" last-modified-when="2024-02-14T06:45:04.937+00:00"><api:citation-count>66</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Interleukin-6 (IL-6) is an important growth and survival factor for myeloma cells. However, the identity of the cells producing IL-6 in vivo remains unclear. Myeloma cells are found closely associated with sites of active bone turnover, and cells of the osteogenic lineage, including bone marrow osteoprogenitors, osteoblasts and bone lining cells, may therefore be ideally placed to synthesize IL-6. We have examined the possibility that human osteogenic cells may produce IL-6 in response to stimulation by myeloma cells. Primary human osteoblasts (hOBs) were isolated from normal donors, co- cultured with the human myeloma cell lines, JJN-3, RPMI-8226 and NCI-H929, and the amount of IL-6 released was determined by enzyme-linked immunosorbent assay (ELISA). All myeloma cells stimulated a significant increase in the production of IL-6 when cultured with hOBs (P &lt; 0.05). Prior fixation of hOBs completely abrogated release of IL-6 in the co-cultures. In contrast, fixed myeloma cells retained the ability to induce IL-6 production, suggesting that hOBs were the principal source of IL-6. Physical separation of myeloma cells from hOBs using transwell inserts caused a partial inhibition of IL-6 release (P &lt; 0.05), whereas the addition of media conditioned by myeloma cells to cultures of hOBs stimulated a significant increase in IL-6 production (P &lt; 0.05). hOBs secreted greater amounts of IL-6 than human bone marrow stromal cells (hBMSCs) (2.2- to 3-5-fold, P &lt; 0.05), but incubating hBMSCs with dexamethasone to stimulate osteoblastic differentiation resulted in an increase in their ability to produce IL-6 (1.7- to 4.8-fold, P &lt; 0.05) and to respond to myeloma cells (P &lt; 0.05). These data clearly indicate that cells of the osteoblast lineage release significant amounts of IL-6 in response to stimulation by myeloma cells and may contribute to the IL-6 that promotes the proliferation and survival of myeloma cells in vivo.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Karadag</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="TR"><api:line type="organisation">Aydin Adnan Menderes University</api:line><api:line type="city">Aydin</api:line><api:line type="country">Turkey</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7003996292</api:identifier></api:identifiers></api:person><api:person><api:last-name>Oyajobi</api:last-name><api:initials>BO</api:initials><api:first-names>BO</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>O</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="US"><api:line type="organisation">Joe R. &amp;amp; Teresa Lozano Long School of Medicine</api:line><api:line type="city">San Antonio</api:line><api:line type="country">United States</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6701681726</api:identifier></api:identifiers></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">UCL Cancer Institute</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005558171</api:identifier></api:identifiers></api:person><api:person><api:last-name>Graham</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57210951349</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="18810" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18810"/></api:links><api:last-name>Russell</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7403934359</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">26635094100</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.2000.01845.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.2000.01845.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.2000.01845.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10691869</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Haematology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>383</api:begin-page><api:end-page>390</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>22</api:day><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>108</api:text></api:field></api:native></api:record><api:record format="native" id="804" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10691869" last-modified-when="2020-04-29T00:32:02.517+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Interleukin-6 (IL-6) is an important growth and survival factor for myeloma cells. However, the identity of the cells producing IL-6 in vivo remains unclear. Myeloma cells are found closely associated with sites of active bone turnover, and cells of the osteogenic lineage, including bone marrow osteoprogenitors, osteoblasts and bone lining cells, may therefore be ideally placed to synthesize IL-6. We have examined the possibility that human osteogenic cells may produce IL-6 in response to stimulation by myeloma cells. Primary human osteoblasts (hOBs) were isolated from normal donors, co-cultured with the human myeloma cell lines, JJN-3, RPMI-8226 and NCI-H929, and the amount of IL-6 released was determined by enzyme-linked immunosorbent assay (ELISA). All myeloma cells stimulated a significant increase in the production of IL-6 when cultured with hOBs (P &lt; 0.05). Prior fixation of hOBs completely abrogated release of IL-6 in the co-cultures. In contrast, fixed myeloma cells retained the ability to induce IL-6 production, suggesting that hOBs were the principal source of IL-6. Physical separation of myeloma cells from hOBs using transwell inserts caused a partial inhibition of IL-6 release (P &lt; 0.05), whereas the addition of media conditioned by myeloma cells to cultures of hOBs stimulated a significant increase in IL-6 production (P &lt; 0.05). hOBs secreted greater amounts of IL-6 than human bone marrow stromal cells (hBMSCs) (2.2- to 3.5-fold, P &lt; 0.05), but incubating hBMSCs with dexamethasone to stimulate osteoblastic differentiation resulted in an increase in their ability to produce IL-6 (1.7- to 4. 8-fold, P &lt; 0.05) and to respond to myeloma cells (P &lt; 0.05). These data clearly indicate that cells of the osteoblast lineage release significant amounts of IL-6 in response to stimulation by myeloma cells and may contribute to the IL-6 that promotes the proliferation and survival of myeloma cells in vivo.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Karadag</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Biochemical and Musculoskeletal Medicine, University of Sheffield Medical School, Sheffield, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Oyajobi</api:last-name><api:initials>BO</api:initials><api:first-names>BO</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>O</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RG</api:initials><api:first-names>RG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10691869</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.2000.01845.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.2000.01845.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.2000.01845.x"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Haematol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Cell Communication</api:keyword><api:keyword scheme="mesh">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin-6</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Osteoblasts</api:keyword><api:keyword scheme="mesh">Stromal Cells</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>383</api:begin-page><api:end-page>390</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>bjh1845</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>13</api:day><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>108</api:text></api:field></api:native></api:record><api:record format="native" id="882063" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10691869" last-modified-when="2024-01-30T19:37:29.97+00:00"><api:citation-count>37</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Interleukin-6 (IL-6) is an important growth and survival factor for myeloma cells. However, the identity of the cells producing IL-6 in vivo remains unclear. Myeloma cells are found closely associated with sites of active bone turnover, and cells of the osteogenic lineage, including bone marrow osteoprogenitors, osteoblasts and bone lining cells, may therefore be ideally placed to synthesize IL-6. We have examined the possibility that human osteogenic cells may produce IL-6 in response to stimulation by myeloma cells. Primary human osteoblasts (hOBs) were isolated from normal donors, co-cultured with the human myeloma cell lines, JJN-3, RPMI-8226 and NCI-H929, and the amount of IL-6 released was determined by enzyme-linked immunosorbent assay (ELISA). All myeloma cells stimulated a significant increase in the production of IL-6 when cultured with hOBs (P &lt; 0.05). Prior fixation of hOBs completely abrogated release of IL-6 in the co-cultures. In contrast, fixed myeloma cells retained the ability to induce IL-6 production, suggesting that hOBs were the principal source of IL-6. Physical separation of myeloma cells from hOBs using transwell inserts caused a partial inhibition of IL-6 release (P &lt; 0.05), whereas the addition of media conditioned by myeloma cells to cultures of hOBs stimulated a significant increase in IL-6 production (P &lt; 0.05). hOBs secreted greater amounts of IL-6 than human bone marrow stromal cells (hBMSCs) (2.2- to 3.5-fold, P &lt; 0.05), but incubating hBMSCs with dexamethasone to stimulate osteoblastic differentiation resulted in an increase in their ability to produce IL-6 (1.7- to 4. 8-fold, P &lt; 0.05) and to respond to myeloma cells (P &lt; 0.05). These data clearly indicate that cells of the osteoblast lineage release significant amounts of IL-6 in response to stimulation by myeloma cells and may contribute to the IL-6 that promotes the proliferation and survival of myeloma cells in vivo.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Biochemical and Musculoskeletal Medicine, University of Sheffield Medical School, Sheffield, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Karadag</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0003-0969-7038</api:identifier></api:identifiers></api:person><api:person><api:last-name>Oyajobi</api:last-name><api:initials>BO</api:initials><api:first-names>BO</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>O</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-1064-3072</api:identifier></api:identifiers></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RG</api:initials><api:first-names>RG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-4136-1828</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-7102-2413</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.2000.01845.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.2000.01845.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.2000.01845.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2141</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10691869</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British journal of haematology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">Osteoblasts</api:keyword><api:keyword scheme="mesh">Stromal Cells</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Interleukin-6</api:keyword><api:keyword scheme="mesh">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh">Cell Communication</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>383</api:begin-page><api:end-page>390</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>26</api:day><api:month>2</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>108</api:text></api:field></api:native></api:record><api:record format="native" id="2926019" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1035352779" last-modified-when="2024-04-14T08:25:45.093+01:00"><api:citation-count>67</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>3</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Karadag</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="TR"><api:line type="organisation">Adnan Menderes University</api:line><api:line type="city">Aydin</api:line><api:line type="country">Turkey</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01003016651.21</api:identifier></api:identifiers></api:person><api:person><api:last-name>Oyajobi</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="US"><api:line type="organisation">The University of Texas Health Science Center at San Antonio</api:line><api:line type="city">San Antonio</api:line><api:line type="state">Texas</api:line><api:line type="country">United States</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0626254733.41</api:identifier></api:identifiers></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0753003365.31</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="18810" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18810"/></api:links><api:last-name>Russell</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0624303260.79</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2141.2000.01845.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2141.2000.01845.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2141.2000.01845.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10691869</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>11.23</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Haematology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3201 Cardiovascular Medicine and Haematology</api:keyword><api:keyword scheme="rcdc">Hematology</api:keyword><api:keyword scheme="rcdc">Stem Cell Research</api:keyword><api:keyword scheme="rcdc">Rare Diseases</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="mesh">Cell Communication</api:keyword><api:keyword scheme="mesh">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin-6</api:keyword><api:keyword scheme="mesh">Multiple Myeloma</api:keyword><api:keyword scheme="mesh">Osteoblasts</api:keyword><api:keyword scheme="mesh">Stromal Cells</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>24</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Bronze OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>383</api:begin-page><api:end-page>390</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.88</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>108</api:text></api:field></api:native></api:record><api:record format="native" id="241361" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000085970600026" last-modified-when="2024-03-14T05:42:14.4+00:00"><api:citation-count>55</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Karadag</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Oyajobi</api:last-name><api:initials>BO</api:initials><api:first-names>BO</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>O</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>RGG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000085970600026&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">295MG</api:identifier><api:identifier scheme="pubmed">10691869</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRITISH JOURNAL OF HAEMATOLOGY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>multiple myeloma</api:keyword><api:keyword>osteoblast</api:keyword><api:keyword>interleukin-6</api:keyword><api:keyword>bone marrow</api:keyword><api:keyword>dexamethasone</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>383</api:begin-page><api:end-page>390</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>108</api:text></api:field></api:native></api:record><api:record format="native" id="24327" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000085970600026" last-modified-when="2014-07-25T11:05:44.613+01:00"><api:citation-count>25</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Karadag</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Oyajobi</api:last-name><api:initials>BO</api:initials><api:first-names>BO</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>O</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Apperley</api:last-name><api:initials>JF</api:initials><api:first-names>JF</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Russell</api:last-name><api:initials>RGG</api:initials><api:first-names>RGG</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>G</api:first-name><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1848" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1848"/></api:links><api:last-name>Croucher</api:last-name><api:initials>PI</api:initials><api:first-names>PI</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>I</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-1048</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRIT J HAEMATOL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>multiple myeloma</api:keyword><api:keyword>osteoblast</api:keyword><api:keyword>interleukin-6</api:keyword><api:keyword>bone marrow</api:keyword><api:keyword>dexamethasone</api:keyword><api:keyword>HUMAN MULTIPLE-MYELOMA</api:keyword><api:keyword>MARROW STROMAL CELLS</api:keyword><api:keyword>MALIGNANT PLASMA-CELLS</api:keyword><api:keyword>HUMAN-BONE</api:keyword><api:keyword>MONOCLONAL GAMMOPATHY</api:keyword><api:keyword>GROWTH-FACTOR</api:keyword><api:keyword>OSTEOTROPIC FACTOR</api:keyword><api:keyword>GENE-EXPRESSION</api:keyword><api:keyword>TUMOR-CELLS</api:keyword><api:keyword>SECRETION</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>383</api:begin-page><api:end-page>390</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>2</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>108</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Communication</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Interleukin-6</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Osteoblasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Stromal Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Osteoblasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Stromal Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Interleukin-6</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Communication</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3201 Cardiovascular Medicine and Haematology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Hematology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Stem Cell Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Rare Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Communication</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Enzyme-Linked Immunosorbent Assay</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Interleukin-6</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Multiple Myeloma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Osteoblasts</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Stromal Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Cells, Cultured</api:keyword><api:keyword origin="record-data" source="wos-lite">multiple myeloma</api:keyword><api:keyword origin="record-data" source="wos-lite">osteoblast</api:keyword><api:keyword origin="record-data" source="wos-lite">interleukin-6</api:keyword><api:keyword origin="record-data" source="wos-lite">bone marrow</api:keyword><api:keyword origin="record-data" source="wos-lite">dexamethasone</api:keyword><api:keyword origin="record-data" source="wos">multiple myeloma</api:keyword><api:keyword origin="record-data" source="wos">osteoblast</api:keyword><api:keyword origin="record-data" source="wos">interleukin-6</api:keyword><api:keyword origin="record-data" source="wos">bone marrow</api:keyword><api:keyword origin="record-data" source="wos">dexamethasone</api:keyword><api:keyword origin="record-data" source="wos">HUMAN MULTIPLE-MYELOMA</api:keyword><api:keyword origin="record-data" source="wos">MARROW STROMAL CELLS</api:keyword><api:keyword origin="record-data" source="wos">MALIGNANT PLASMA-CELLS</api:keyword><api:keyword origin="record-data" source="wos">HUMAN-BONE</api:keyword><api:keyword origin="record-data" source="wos">MONOCLONAL GAMMOPATHY</api:keyword><api:keyword origin="record-data" source="wos">GROWTH-FACTOR</api:keyword><api:keyword origin="record-data" source="wos">OSTEOTROPIC FACTOR</api:keyword><api:keyword origin="record-data" source="wos">GENE-EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">TUMOR-CELLS</api:keyword><api:keyword origin="record-data" source="wos">SECRETION</api:keyword><api:keyword scheme="for" origin="issn-inferred">1102 Cardiorespiratory Medicine and Haematology</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Immunology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3201 Cardiovascular medicine and haematology</api:keyword></api:keywords></api:all-labels><api:journal issn="0007-1048" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973665" title="British Journal of Haematology"><api:records><api:record source-name="summary"><api:title>British Journal of Haematology</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/804/relationships"/></api:object></api:result></api:response>